The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
For lots of people, the ‘fear of the unknown’ stops them from accessing sexual health testing and support. In this episode, Jim and Andy remember how they used to feel going into clinics and where they went for support.
New research from South Africa provides insights into the factors associated with retention of adolescents in HIV care, suggesting relatively low‐cost interventions could significantly improve adherence and retention in care.
A simple questionnaire has been developed and validated in Harare, Zimbabwe, to pre-screen adolescents for HIV testing.
Sharing your #HIV status can be daunting at any age, but for young people it can be even more challenging. In this episode, Gracious and Theresa share their experiences telling loved ones about their HIV status.
Epidemics of HIV and HPV are inherently interconnected – and when they meet in the context of weak health systems, their effects are amplifed.
Outreach workers identify a number of personal, social, and structural challenges that impede efforts to prevent mother-to-child transmission of HIV in India.
What are the pros and cons of dating older people? In this episode of Talking HIV, James and Tsholofelo discuss the risks and realities of dating somebody older.
On International Safe Abortion Day (28 September), we give an overview of the link between HIV and abortion and the need for broader sexual reproductive health rights for women.
Surprising research from Hong Kong reveals that providing PrEP to a third of gay men averts more new infections than only targeting gay men most at risk.
Avert’s podcast ‘Talking HIV’ is back again. This time sharing the voices of young people from across Southern Africa. In the first episode, Lisa and Godknows share their experiences of sex ed. at school.
Getting on top of the tuberculosis epidemic requires renewed attention, and bringing HIV out of isolation.
Opportunities to increase access to the hepatitis C cure exist – but strong political will is needed and many countries are failing to benefit from cheaper generics.